A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer

Paclitaxel and capecitabine, which have distinct mechanisms of action and toxicity profiles, have each shown high activity as single agents in gastric cancer. Synergistic interaction between these two drugs was suggested by taxane-induced upregulation of thymidine phosphorylase. We, therefore, evalu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kang, H J, Chang, H M, Kim, T W, Ryu, M-H, Sohn, H-J, Yook, J H, Oh, S T, Kim, B S, Lee, J-S, Kang, Y-K
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2008
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361449/
https://ncbi.nlm.nih.gov/pubmed/18219288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604186
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados